These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 15566253)

  • 1. [Risk patients are often insufficiently treated. LDL cholesterol to be held down even more vigorously].
    MMW Fortschr Med; 2004 Oct; 146(44):56-7. PubMed ID: 15566253
    [No Abstract]   [Full Text] [Related]  

  • 2. [Type 2 diabetics are high risk patients. Concerning LDL-cholesterol to approach effectively to two sources].
    MMW Fortschr Med; 2005 Nov; 147(44):52-3. PubMed ID: 16302495
    [No Abstract]   [Full Text] [Related]  

  • 3. [Statin and absorption inhibitor work synergistically. More risk patient reach LDL cholesterol goal value].
    MMW Fortschr Med; 2007 Apr; 149(17):56-7. PubMed ID: 17674912
    [No Abstract]   [Full Text] [Related]  

  • 4. [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly].
    MMW Fortschr Med; 2005 Aug; 147(33-34):50-1. PubMed ID: 16138640
    [No Abstract]   [Full Text] [Related]  

  • 5. [Target values are more often attainable. Almost doubly so many patients with values under 100mg/dl].
    MMW Fortschr Med; 2004 Oct; 146(44):57. PubMed ID: 15566254
    [No Abstract]   [Full Text] [Related]  

  • 6. [Considerable remaining risk in unchecked LDL lowering. Is the HDL increase the way out?].
    MMW Fortschr Med; 2006 Jun; 148(24):6, 8. PubMed ID: 16856232
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lowering LDL cholesterol frequently does not adhere to guidelines. Also regard intestinal cholesterol source].
    MMW Fortschr Med; 2005 Jun; 147(23):48-9. PubMed ID: 15981908
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dual cholesterol inhibition. More high risk patients achieve LDL cholesterol values below 100 mg/dl].
    MMW Fortschr Med; 2008 Jun; 150(23):39. PubMed ID: 18575369
    [No Abstract]   [Full Text] [Related]  

  • 9. [Considerable LDL lowering is advantageous].
    MMW Fortschr Med; 2005 Sep; 147(35-36):9. PubMed ID: 16180563
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lowering cholesterol becomes easier. Combining instead of increasing dosage].
    MMW Fortschr Med; 2003 Jan; 145(3-4):59. PubMed ID: 12619241
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cholesterol resorption inhibition prevents high statin doses. Lipid lowering in double-pack].
    MMW Fortschr Med; 2002 Nov; 144(48):60. PubMed ID: 12532550
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lowering of LDL cholesterol prevents cardiovascular diseases. "Normal values" are too high--treatment time is a crucial factor].
    Rudling M
    Lakartidningen; 2006 Oct 25-31; 103(43):3278-82. PubMed ID: 17117659
    [No Abstract]   [Full Text] [Related]  

  • 13. [The 10-minute consultation: accidently discovered hypercholesteremia].
    Tatò F
    MMW Fortschr Med; 2004 Sep; 146(35-36):59-60. PubMed ID: 15540545
    [No Abstract]   [Full Text] [Related]  

  • 14. Your cholesterol might have to come down--way down.
    Comarow A
    US News World Rep; 2001 May; 130(21):46-8. PubMed ID: 11383131
    [No Abstract]   [Full Text] [Related]  

  • 15. Critical appraisal of revised cholesterol guidelines for the very high-risk patient.
    Rosenson R; Lloyd-Jones D;
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):173-8. PubMed ID: 15739256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the change in the Framingham Risk Score calculator between the 2006 and 2009 Canadian lipid guidelines.
    Armstrong DW; Brouillard D; Matangi MF
    Can J Cardiol; 2011; 27(2):167-70. PubMed ID: 21459264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin.
    Sampalis JS; Bissonnette S; Habib R; Boukas S;
    Ann Pharmacother; 2007 Sep; 41(9):1345-51. PubMed ID: 17666579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preventing infarct by lowering LDL. Is 100 the upper limit for every diabetic patient?].
    MMW Fortschr Med; 2003 Sep; 145(38):60. PubMed ID: 14603687
    [No Abstract]   [Full Text] [Related]  

  • 19. [Good prevention of type 2 diabetes with lipid-lowering statin therapy. Intervention studies support active treatment of risk patients].
    Nilsson PM; Attvall S; Båvenholm P
    Lakartidningen; 2004 Nov; 101(47):3798, 3801-2, 3804. PubMed ID: 15609534
    [No Abstract]   [Full Text] [Related]  

  • 20. [To lessen the cardiovascular risk of the diabetic patient. Atorvastatin of use for diabetic patients without coronary disease, too].
    MMW Fortschr Med; 2005 Aug; 147(33-34):51. PubMed ID: 16138641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.